title: [Comparative analysis of programs of complete correction osteogenic in patients with chronic pancreatitis].
abstract: SUMMARY The expediency of Risendros using in the complex treatment of the patients with a chronic pancreatitis and osteodeficiency syndrome has been proved. As a result the status of the bone mineralization is improved, the mineral density of the bone tissue is increased.
authors: L S
authors: LS
authors: Babinets'
authors: I V
authors: IV
authors: Semenova
authors: I O
authors: IO
authors: Borovyk
mesh_terms: D000328:Adult; D000368:Aged; D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy* / Q000209:etiology; D050500:Pancreatitis, Chronic / Q000150:complications*; D000068296:Risedronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D000068296:Risedronic Acid; D012968:Etidronic Acid